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Sarcopenic obesity (SO) is characterised by the concurrent presence of sarcopenia and 34 
excess adiposity. Telomere shortening has been associated with sarcopenia and obesity 35 
alone but the association between SO and telomere length (TL) has not been investigated. 36 
This study aimed to investigate SO and TL in an adult population. Data were from 5,397 37 
individuals (mean age=44.7 years, 51.3% male) enrolled in the National Health and Nutrition 38 
Examination Survey. Body composition (BC) was assessed by Dual Energy X-Ray 39 
Absorptiometry. Two models were used to assess SO: a BC model including four 40 
phenotypes derived from the combination of high or low adiposity and muscle mass; and, a 41 
truncal fat mass to appendicular skeletal mass ratio (TrFM/ASM). TL was assessed using 42 
quantitative polymerase chain reaction and expressed as base pairs. The mean TL, relative 43 
to the reference DNA, was calculated and expressed as the mean T/S ratio. A General 44 
Linear Model was applied to determine associations between TL for SO. In adjusted 45 
analysis, only individuals with SO, defined as the presence of high adiposity-low muscle 46 
mass (four-phenotype model), had significantly shorter telomeres (p=0.05) than the 47 
reference group (i.e. low adiposity-high muscle mass), with a mean T/S ratio of 1.02 (95%CI: 48 
0.98–1.05) compared to 1.05 (95%CI: 1.01–1.09), respectively. TrFM/ASM was not 49 
associated with TL. Preliminary findings suggest that sarcopenia and obesity may act 50 
synergistically to shorten telomeres. 51 
 52 






Sarcopenic obesity (SO) is defined by the concurrent presence of low muscle mass 57 
(sarcopenia) and high adiposity (obesity) [1]. SO appears to confer a greater risk for cardio-58 
metabolic diseases and mortality, than either sarcopenia or obesity alone [1].  59 
Telomeres are DNA-protein structures located at the ends of chromosomes, which protect the 60 
genome from inter-chromosomal fusion, nucleolytic degradation and genome instability [2]. In 61 
the absence of sufficient telomerase activity, telomeres are shortened, and this has been used 62 
as a biomarker of biological ageing [2]. Individuals with shorter telomeres may have a greater 63 
risk of cardio-metabolic disorders and mortality [2]. However, even though telomere shortening 64 
has been associated with sarcopenia and obesity separately [3,4], the link between SO and 65 
telomere length (TL) has not been investigated to determine whether SO may represent a 66 
greater risk factor for accelerated ageing and age-related cardio-metabolic disorders.  67 
Therefore, the aim of this study was to explore the relationship between SO and TL in an adult 68 
population-representative cohort recruited as part of National Health and Nutrition 69 
Examination Survey (NHANES). 70 
 71 
Material & Methods 72 
National Health and Nutrition Examination Survey  73 
The data for this study were obtained from the NHANES surveys conducted between 1999 74 
and 2002. Survey procedures are available online at http://www.cdc.gov/nchs/nhanes.htm 75 
(accessed March 2021). The survey used a complex, multistage probability sampling design 76 
to ensure that the sample was representative of non-institutionalised adult (≥18 years) civilians 77 
in the United States (US) [5]. The sample included 7,110 individuals. Individuals that had 78 
missing data for mean telomere (T/S) ratio (n = 1,712) or had a coefficient of variation for 79 
mean T/S ratio (mean T/S ratio/standard deviation of mean T/S ratio) that was > 1 (n = 1), 80 




Dual energy x-ray absorptiometry (DXA) 83 
Body composition (BC) was assessed by DXA using a Hologic QDR-4500A. Participants were 84 
excluded if they were pregnant or they did not fit on the DXA scanner (weight > 136.1 kg and 85 
height > 195.6 cm). Participants were also excluded if they had been exposed to nuclear 86 
medicine in the previous three days or radiographic contrast material in the previous seven 87 
days.  88 
Body Composition Phenotypes 89 
Body composition phenotypes were defined using three separate models: 1) a four-phenotype 90 
model; 2) the ratio between truncal fat mass (TrFM) and appendicular skeletal muscle mass 91 
(ASM); and 3) body mass index (BMI). The four-phenotype model divides individuals into four 92 
categories based on levels of adiposity and muscle mass, and previously established 93 
reference curves [6]. The four groups were: low adiposity and high muscle mass (LA-HM); low 94 
adiposity and low muscle mass (LA-LM); high adiposity and high muscle mass (HA-HM); and, 95 
high adiposity and low muscle mass (HA-LM). Individuals with a HA-LM phenotype were 96 
considered as having sarcopenic obesity. The TrFM/ASM ratio model divided individuals into 97 
three categories based on the centile of TrFM/ASM ratio derived from population-based 98 
reference curves [7]. These categories were: < 15th centile; 15-84th centile; and, ≥ 85th centile. 99 
SO was defined as a TrFM/ASM ratio ≥ 85th centile of the reference curve. BMI was calculated 100 
by weight (kg) /height2 (m). Participants were classified as normal weight (BMI = 18.5 – 24.9 101 
kg/m2), overweight (BMI = 25.0 – 29.9 kg/m2) or obesity (BMI ≥ 30.0 kg/m2). 102 
Telomere Length 103 
Telomere length was analysed using whole blood and qPCR and reported as base pairs. The 104 
mean TL, relative to the reference DNA, was calculated and expressed as the mean T/S ratio. 105 
Assay runs with control values beyond two standard deviations of the mean of all runs, were 106 
excluded (< 6% of runs). Outliers within samples were identified and excluded (< 2% of 107 
samples). The interassay coefficient of variation was 6.5%. 108 
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Statistical Analysis 109 
Statistical analysis was conducted using the SPSS Complex Samples module according to 110 
NHANES protocols found online at https://wwwn.cdc.gov/nchs/nhanes/tutorials/Module4.aspx 111 
(accessed March 2021). Analysis was prepared by adjusting for strata, clusters, and a 4-year 112 
sample weight. Descriptive statistics were calculated through complex analysis unless 113 
otherwise stated, and presented as mean with standard error (continuous variables) or as 114 
percentages of total sample weight (categorical variables). A General Linear Model (GLM) 115 
was applied to the three models of BC, with the mean T/S ratio selected as the outcome 116 
variable on each occasion. Analyses were adjusted for age, sex, ethnicity, education, physical 117 
activity, smoking, alcohol intake and general health condition, which are covariates that have 118 
been described previously [5]. The GLM analysis produced mean T/S values for each 119 
phenotype, in addition to 95% confidence intervals (CI), and was used to test for statistical 120 
significance between each phenotype and the reference phenotypes (BC = LA-HM; 121 
TrFM/ASM ≤ 15th centile; BMI = normal weight). The mean T/S ratio value and corresponding 122 
CIs of each phenotype were converted to TL in base pairs (bp) using a formula specific to the 123 
assay (3,274 + 2,413 * (T/S)), to support the interpretation of the results. Analyses were 124 
conducted using IBM SPSS Version 27 for Windows. A p-value ≤ 0.05 was considered as 125 
statistically significant.  126 
Results 127 
The study sample included 5,397 individuals, with a mean age of 44.7 years (51.3% male). 128 
The four-component BC phenotype model classified 25.0% of individuals as LA-HM, 24.7% 129 
as LA-LM, 27.9% as HA-HM and 22.4% as HA-LM (SO). The TrFM/ASM model classified 130 
14.7% of individuals as < 15th centile, 70.5% as 15 - 84th centile and 14.7% as ≥ 85th centile 131 
(SO). The BMI model classified 33.8% of individuals as normal weight, 36.0% as overweight, 132 
and 29.6% as individuals with obesity (Table 1). 133 
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In adjusted analyses, only subjects with the HA-LM phenotype had significantly shorter 134 
telomeres than the reference group LA-HM, with a mean T/S value of 1.02 (95%CI: 0.98 - 135 
1.05, p = 0.05) compared to 1.05 (95%CI: 1.01–1.09), respectively. The mean T/S ratio for the 136 
HA-LM group corresponded to a TL of 5735 bp (95%CI: 5650 – 5820), which was significantly 137 
shorter (difference: -87 bp, 95%CI: -20 – -145 bp, p=0.05) compared the reference group LA-138 
HM. No significant association was found between TrFM/ASM phenotypes and TL, or between 139 
BMI groups and TL (Table 2). 140 
Discussion 141 
These preliminary results suggest that SO may be associated with telomere shortening and 142 
may represent an important risk factor for accelerated ageing than sarcopenia and obesity 143 
alone. Sarcopenia and obesity have been associated individually with greater inflammation 144 
and generation of reactive oxygen species [2,8], which are linked to single-strand breaks in 145 
DNA and have a high affinity for the G-rich fragments within telomeres [9]. Hence, the co-146 
occurrence of sarcopenia and obesity may exacerbate these processes and lead to greater 147 
telomere shortening.  148 
The TrFM/ASM model found no significant association between SO and TL; this result was 149 
unexpected as truncal fat accumulation has been associated with greater impairment of 150 
cardio-metabolic health [10]. Further research is needed to investigate whether whole-body 151 
fat mass and truncal fat mass may differ in their associations with mechanisms related to 152 
telomere shortening and ageing processes. 153 
The stratification of the population by the four-component BC phenotype model showed a 154 
significant association in adjusted models between the SO (HA-LM) phenotype and TL 155 
whereas no significant association was found between BMI groups and telomere shortening. 156 
These findings are contrasting with previous literature indicating a significant association 157 
between BMI and telomere shortening; a potential reason for the difference could be attributed 158 
to the difference in sample size as the previous analysis was based on eighty-seven distinct 159 
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study samples were including 146,114 individuals  [4]. The key observation of this study is that 160 
the concurrence of sarcopenia and obesity may produce a greater, synergistic effect on 161 
telomeres than either sarcopenia or obesity alone. Mechanisms that could explain telomere 162 
shortening include increased oxidative stress, endocrine dysfunction and chronic inflammation 163 
[11] and previous studies have reported greater levels of oxidative stress and inflammation in 164 
the SO phenotype compared to sarcopenia and obesity alone [12,13].  165 
This study has numerous strengths. This analysis included a large number of individuals that 166 
were multi-ethnic and representative of the adult civilian population in the US. BC was 167 
assessed using DXA, which is currently the preferred field method of assessment based upon 168 
accuracy and reliability. The analyses were also adjusted for demographic, health and lifestyle 169 
covariates. TL was measured by a well-established protocol, which included stringent quality 170 
control measures such as the identification and exclusion of outlying values. However, this 171 
study also has limitations. Subjects were excluded from DXA-assessment if they weighed over 172 
136.1 kg or were taller than 195.6 cm, which may render these findings unrepresentative of 173 
those with extreme body types. The classification of sarcopenia did not include the 174 
assessment of muscle function, which is a distinct component of sarcopenia assessment. It 175 
was not possible to investigate a causal association between BC phenotypes and telomere 176 
shortening due to the cross-sectional design of the study. 177 
In conclusion, these preliminary results indicate a significant association between SO and 178 
telomere shortening and may suggest that sarcopenia and obesity may act synergistically on 179 
the ageing process. Future work should be conducted to further explore these associations in 180 






This research was funded by Nottingham University Core Research Budget. 185 
Competing interests 186 
No conflicts of interest to declare  187 
Authors' contributions 188 
MS is the guarantor of this work and, as such, had full access to all the data in the study and 189 
takes responsibility for the integrity of the data and the accuracy of the data analysis. MS 190 
conceived the analysis conducted in this paper. TG and MS conducted the analysis and wrote 191 
the manuscript. All authors contributed to the analysis, discussion, and interpretation of data, 192 











1 Roh E, Choi KM. Health Consequences of Sarcopenic Obesity: A Narrative Review. 202 
Front Endocrinol (Lausanne) 2020;11. https://doi.org/10.3389/fendo.2020.00332. 203 
2 Shammas MA. Telomeres, lifestyle, cancer, and aging. Curr Opin Clin Nutr Metab Care 204 
2011;14. https://doi.org/10.1097/MCO.0b013e32834121b1. 205 
3 Lorenzi M, Bonassi S, Lorenzi T, Giovannini S, Bernabei R, Onder G. A review of 206 
telomere length in sarcopenia and frailty. Biogerontology 2018;19. 207 
https://doi.org/10.1007/s10522-018-9749-5. 208 
4 Gielen M, Hageman GJ, Antoniou EE, Nordfjall K, Mangino M, Balasubramanyam M, 209 
et al. Body mass index is negatively associated with telomere length: A collaborative cross-210 
sectional meta-analysis of 87 observational studies. Am J Clin Nutr 2018;108. 211 
https://doi.org/10.1093/ajcn/nqy107. 212 
5 Zipf G, Chiappa M, Porter KS, Lewis BG, Ostchega Y, Dostal J. National Health And 213 
Nutrition Examination Survey: Plan and operations, 1999-2010. Vital Heal Stat Ser 1 Programs 214 
Collect Proced 2013. 215 
6 Prado CMM, Siervo M, Mire E, Heymsfield SB, Stephan BCM, Broyles S, et al. A 216 
population-based approach to define body-composition phenotypes. Am J Clin Nutr 2014;99. 217 
https://doi.org/10.3945/ajcn.113.078576. 218 
7 Siervo M, Prado CM, Mire E, Broyles S, Wells JC, Heymsfield S, et al. Body 219 
composition indices of a load-capacity model: Gender-and BMI-specific reference curves. 220 
Public Health Nutr 2015;18. https://doi.org/10.1017/S1368980014001918. 221 
8 Schrager MA, Metter EJ, Simonsick E, Ble A, Bandinelli S, Lauretani F, et al. 222 




9 Kawanishi S, Oikawa S. Mechanism of telomere shortening by oxidative stress. Ann. 225 
N. Y. Acad. Sci., vol. 1019, 2004. https://doi.org/10.1196/annals.1297.047. 226 
10 Lee SW, Son JY, Kim JM, Hwang SS, Han JS, Heo NJ. Body fat distribution is more 227 
predictive of all-cause mortality than overall adiposity. Diabetes, Obes Metab 2018;20. 228 
https://doi.org/10.1111/dom.13050. 229 
11     Sahin E, Colla S, Liesa M, Moslehi J, Müller FL, Guo M, et al. Telomere dysfunction 230 
induces metabolic and mitochondrial compromise. Nature. 2011;470:359–6517. 231 
12   Batsis JA, Mackenzie TA, Jones JD, Lopez-Jimenez F, Bartels SJ. Sarcopenia, 232 
sarcopenic obesity and inflammation: Results from the 1999-2004 National Health and 233 
Nutrition Examination Survey. Clin Nutr. 2016;35(6):1472-1483. 234 
13      Barazzoni R, Bischoff SC, Boirie Y, Busetto L, Cederholm T, Dicker D, et al. 235 
Sarcopenic obesity: Time to meet the challenge. Clin Nutr. 2018;37:1787-1793.   236 
11 
 
Table 1: Characteristics of the sample population. Values are through complex analysis unless 
otherwise stated. 
Metric Value 
Participants, na 5397 
Male, % 51.3 
Age, mean (SE) 44.7 (0.4) 
BMI (kg/m2) 27.7 (0.06) 
Ethnicity 
 Mexican Hispanic, % 7.3 
 Other Hispanic, % 7.0 
 Non-Hispanic White, % 72.7 
 Non-Hispanic Black, % 9.0 
 Other Race - Including Multi-Racial, % 3.9 
Education (highest level obtained) 
 Less Than 9th Grade, % 6.2 
 9-11th Grade (Includes 12th grade with no diploma), % 13.7 
 High School Grad/GED or Equivalent, % 26.4 
 Some College or AA degree, % 28.8 
 College Graduate or above, % 24.8 
 Refused, % <0.1 
 Don’t Know, % 0.1 
Physical activity 
 Sits during the day and does not walk a lot, % 23.1 
 Stands or walks a lot during the day but does not carry or lift 
things often, % 
50.0 
 Lifts light loads or climbs stairs/hills often, % 18.6 
 Performs heavy work or carries heavy loads, % 8.2 
 Refused, % <0.1 
 Don’t Know, % 0.1 
Alcohol intake, mean gm/day (SE) 12.4 (0.8) 
General Health Condition 
12 
 
 Excellent, % 24.2 
 Very Good, % 33.6 
 Good, % 28.3 
 Fair, % 11.5 
 Poor, % 2.3 
 Refused, % 0.0 
 
Don’t Know, % <0.1 
Smoking (frequency of cigarette use) 
 Every Day, % 42.4 
 Some Days, % 8.0 
 Not At All, % 49.6 
 Refused, % 0.0 
 Don’t Know, % 0.0 
Four-phenotype model classificationb 
 
LA-HM, % 25.0 
 
LA-LM, % 24.7 
 
HA-HM, % 27.9 
 
HA-LM (SO), % 22.4 
TrFM/ASM ratio classificationc 
 
 
<15th centile, % 14.7 
 
15-84th centile, % 70.5 
 
>= 85th centile (SO), % 14.8 
BMI classificationd  
 Healthy, % 33.8 
 Overweight, % 36.0 
 Obesity, % 29.6 
T/S ratio, mean (SE) 1.06 (0.01) 
a Complex analysis not taken into account. 237 
b LA is low adiposity, HA is high adiposity, LM is low muscle mass and HM is high muscle mass. 238 
c TrFM is truncal fat mass, ASM is appendicular skeletal mass.  239 
d BMI is body mass index 240 
e The mean telomere length, relative to the reference DNA, was calculated and expressed as the mean T/S ratio. 241 
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Table 2: Mean T/S ratio and telomere length in base pairs for body composition phenotypes, based on four-phenotype and TrFM/ASM model classifications. 
 
Unadjusted  Adjusted 
Mean T/S ratioc Telomere length 
(base pairs) 
 
Mean T/S ratioc Telomere length 
(base pairs) 
 
Mean 95% CI Mean 95% CI P-value Mean 95% CI Mean 95% CI P-value 
BMI 
Normal weight (reference) 1.10 1.07 – 1.13 5930 5851 - 6009  1.06 1.03 – 1.09 5829 5747 - 5911  
Overweight 1.05 1.02 – 1.09 5813 5729 - 5897 0.003 1.04 1.00 – 1.08 5790 5698 – 5883 0.22 
Obesity 1.04 1.01 – 1.07 5780 5701 - 5859 <0.001 1.04 1.01 – 1.07 5777 5705 - 5850 0.07 
Four-phenotype model classificationa 
LA-HM (reference) 1.08 1.05 - 1.12 5902 5815 - 5990 
 
1.05 1.01 - 1.09 5822 5724 - 5920 
 
LA-LM 1.04 1.01 - 1.07 5799 5728 - 5871 0.01 1.04 1.01 - 1.07 5798 5726 - 5870 0.61 
HA-HM 1.07 1.04 - 1.11 5870 5784 - 5957 0.32 1.06 1.02 - 1.10 5842 5738 - 5946 0.64 
HA-LM (SO) 1.04 1.00 - 1.07 5790 5708 - 5872 0.004 1.02 0.98 - 1.05 5735 5650 - 5820 0.05 
TrFM/ASM classificationb 
<15th centile (reference) 1.10 1.05 - 1.15 5937 5819 - 6054 
 
1.07 1.02 - 1.12 5858 5736 - 5979 
 
15-84th centile 1.05 1.02 - 1.08 5829 5754 - 5903 0.01 1.04 1.01 - 1.07 5797 5721 - 5874 0.15 
>=85th centile (SO) 1.05 1.02 - 1.08 5818 5750 - 5885 0.02 1.03 0.99 - 1.07 5767 5678 - 5857 0.16 
aLA is low adiposity, HA is high adiposity, LM is low muscle mass and HM is high muscle mass.  
bTrFM is truncal fat mass, ASM is appendicular skeletal mass.  
cThe mean telomere length, relative to the reference DNA, was calculated and expressed as the mean T/S ratio. 
Significant results are highlighted in bold. 
